Platelets are concentrated from the blood of a patient. The platelets are treated by a method such as ultrasound or agitation to obtain platelet releasate. This releasate as a whole or a component thereof is formulated into an injectable formulation which is administered to the same patient the platelets were extracted from in order to treat the patient's cancer.

 
Web www.patentalert.com

< ILK inhibitors for the treatment of renal disease

> Methods for the formulation and manufacture of artesunic acid for injection

> GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
~ 00587